Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-23-000231
Filing Date
2023-05-03
Accepted
2023-05-03 08:56:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 24520
  Complete submission text file 0000898432-23-000231.txt   26265
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Subject) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-86686 | Film No.: 23881900
SIC: 2834 Pharmaceutical Preparations

Mailing Address 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B BUNDANG-GU, SEONGNAM-SI GYEONGGI-DO M5 13488
Business Address 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B BUNDANG-GU, SEONGNAM-SI GYEONGGI-DO M5 13488 82-31-628-3200
Genexine Inc. (Filed by) CIK: 0001834377 (see all company filings)

EIN.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D/A